Cited by 669Virus-based gene therapy researchImmunotherapy and Immune ResponsesSARS-CoV-2 and COVID-19 Research

The DOI matches its Crossref record; 132 of the 134 references it cites were found in a registry or an index.

Adenoviruses as vaccine vectors

Open access

Tatsis, Nia, Ertl, Hildegund C.J.·2004·Molecular Therapy

DOI 10.1016/j.ymthe.2004.07.013PMC PMC7106330

Open this paper in CoChat — free account

Abstract

Adenoviruses have transitioned from tools for gene replacement therapy to bona fide vaccine delivery vehicles. They are attractive vaccine vectors as they induce both innate and adaptive immune responses in mammalian hosts. Currently, adenovirus vectors are being tested as subunit vaccine systems for numerous infectious agents ranging from malaria to HIV-1. Additionally, they are being explored as vaccines against a multitude of tumor-associated antigens. In this review we describe the molecular biology of adenoviruses as well as ways the adenovirus vectors can be manipulated to enhance their efficacy as vaccine carriers. We describe methods of evaluating immune responses to transgene products expressed by adenoviral vectors and discuss data on adenoviral vaccines to a selected number of pathogens. Last, we comment on the limitations of using human adenoviral vectors and provide alternatives to circumvent these problems. This field is growing at an exciting and rapid pace, thus we have limited our scope to the use of adenoviral vectors as vaccines against viral pathogens.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2004.07.013

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“3 , are now available [61] [62] [63] [64] .”
Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Innate immune recognition: mechanisms and pathways
Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033
Self-citation
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793
Development of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655

Flagged first, then by citations

Show all 134 references

2 of the 134 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Fisher, 2000, Protection and retargeting of adenovirus using a multifunctional hydrophilic polymer, Mol. Ther., 1S, 57

Sorted by citations

Items 401–500 of 665

Combined mTOR Inhibition and OX40 Agonism Enhances CD8+ T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines
Bassett, J. D., Swift, S. L., VanSeggelen, H., Hammill, J. A., McGray, A. R., Evelegh, C. M., Wan, Y., & Bramson, J. L. (2011) · Molecular Therapy · doi:10.1038/mt.2011.281 · Cited by 11
Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS
Klonjkowski, B., Klein, D., Galea, S., Gavard, F., Monteil, M., Duarte, L., Fournier, A., Sayon, S., Górna, K., Ertl, R., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.086 · Cited by 11
Effect of Preexisting Immunity to Adenovirus on Transgene Product-Specific Genital T Cell Responses on Vaccination of Mice With a Homologous Vector
Haut, L. H., Ratcliffe, S. J., Pinto, A. R., & Ertl, H. C. J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq161 · Cited by 11
Self-citation
The Quest for Immunity: Exploring Human Herpesviruses as Vaccine Vectors
Kamel, M. S., Munds, R. A., & Verma, M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216112 · Cited by 10
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response
Yasmin, H., Saha, S., Butt, M. T., Modi, R. K., George, A. J. T., & Kishore, U. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-67452-6_6 · Cited by 10
Recombinant adenovirus expression of FMDV P1-2A and 3C protein and its immune response in mice
Guo, C., Zhang, C., Zheng, H., & Huang, Y. (2013) · Research in Veterinary Science · doi:10.1016/j.rvsc.2013.05.001 · Cited by 10
Proteolytic Cleavage of Bovine Adenovirus 3-Encoded pVIII
Gaba, A., Ayalew, L. E., Makadiya, N., & Tikoo, S. K. (2017) · Journal of Virology · doi:10.1128/jvi.00211-17 · Cited by 10
T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination
Hemmi, M., Tachibana, M., Fujimoto, N., Shoji, M., Sakurai, F., Kobiyama, K., Ishii, K. J., Akira, S., & Mizuguchi, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01456 · Cited by 11
Baited vaccines: A strategy to mitigate rodent‐borne viral zoonoses in humans
Mendoza, E. J., Warner, B. M., Kobinger, G., Ogden, N. H., & Safronetz, D. (2018) · Zoonoses and Public Health · doi:10.1111/zph.12487 · Cited by 10
Breaking Entry-and Species Barriers: LentiBOOST® Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5
Strack, A., Deinzer, A., Thirion, C., Schrödel, S., Dörrie, J., Sauerer, T., Steinkasserer, A., & Knippertz, I. (2022) · Viruses · doi:10.3390/v14010092 · Cited by 10
Seroprevalence of neutralizing antibodies against adenovirus type 26 and 35 in healthy populations from Guangdong and Shandong provinces, China
Yi, H., Wang, Q., Deng, J., Li, H., Zhang, Y., Chen, Z., Ji, T., Liu, W., Zheng, X., Ma, Q., et al. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.06.006 · Cited by 10
The Early Activation of CD8+ T Cells Is Dependent on Type I IFN Signaling following Intramuscular Vaccination of Adenovirus Vector
Hemmi, M., Tachibana, M., Tsuzuki, S., Shoji, M., Sakurai, F., Kawabata, K., Kobiyama, K., Ishii, K. J., Akira, S., & Mizuguchi, H. (2014) · BioMed Research International · doi:10.1155/2014/158128 · Cited by 12
Technologies for Making New Vaccines
Ahmed, S. S., Ellis, R. W., & Rappuoli, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00066-3 · Cited by 10
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results
Agrati, C., Castilletti, C., Battella, S., Cimini, E., Matusali, G., Sommella, A., Sacchi, A., Colavita, F., Contino, A. M., Bordoni, V., et al. (2022) · npj Vaccines · doi:10.1038/s41541-022-00531-8 · Cited by 9
Maternal immunization with a recombinant adenovirus-expressing fusion protein protects neonatal cotton rats from respiratory syncytia virus infection by transferring antibodies via breast milk and placenta
Shao, H.-Y., Chen, Y.-C., Chung, N., Lu, Y.-J., Chang, C., Yu, S., Liu, C., & Chow, Y. (2018) · Virology · doi:10.1016/j.virol.2018.06.009 · Cited by 11
Transient IL-10 receptor blockade can enhance CD8+T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen
Clutton, G., Bridgeman, A., Reyes‐Sandoval, A., Hanke, T., & Dorrell, L. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1009809 · Cited by 9
Development of Group B Adenoviruses as Gene Transfer Vectors
Stone, D., Paolo, N. C. D., & Libber, A. (2006) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2006.10648067 · Cited by 9
Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia
Grinshtein, N., Yang, T.-C., Parsons, R., Millar, J., Denisova, G. F., Dissanayake, D., Leitch, J., Wan, Y., & Bramson, J. L. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.018 · Cited by 9
Adenoviruses
Allard, A., & Vantarakis, A. (2018) · Michigan State University eBooks · doi:10.14321/waterpathogens.11 · Cited by 9
Simian recombinant adenovirus delivered by the mucosal route modulates γδ T cells from murine genital tract
Lanza, S. R., Menin, Á., Ertl, H. C. J., Báfica, A. L. B., & Pinto, A. R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.080 · Cited by 9
Self-citation
Comprehensive strategies for constructing efficient CRISPR/Cas based cancer therapy: Target gene selection, sgRNA optimization, delivery methods and evaluation
Paranthaman, S., Uthaiah, C. A., Md, S., & Alkreathy, H. M. (2025) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2025.103497 · Cited by 8
Present and future prospects of vaccines: protecting humanity against emerging and re-emerging infectious diseases
Gonal, B. N., Dalbanjan, N. P., Kadapure, A. J., Shubham, K. R., Kumar, S. K. P., & Arakera, S. B. (2025) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2025.100908 · Cited by 8
Upstream Bioprocess for Adenovirus Vectors
Fernandes, P., Silva, A. C., Coroadinha, A. S., & Alves, P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800276-6.00006-1 · Cited by 8
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2
Deshmukh, R., Harwansh, R. K., Garg, A., Mishra, S., Agrawal, R., & Jangde, R. (2024) · Current Genomics · doi:10.2174/0113892029291098240129113500 · Cited by 9
Type-I IFN signaling is required for the induction of antigen-specific CD8+ T cell responses by adenovirus vector vaccine in the gut-mucosa
Shoji, M., Tachibana, M., Katayama, K., Tomita, K., Tsuzuki, S., Sakurai, F., Kawabata, K., Ishii, K. J., Akira, S., & Mizuguchi, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.056 · Cited by 8
Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses
Ko, E., Hait, S. H., Enyindah-Asonye, G. M., Rahman, M. A., Hoang, T. N., & Robert-Guroff, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00779 · Cited by 8
Merits of the ‘good’ viruses: the potential of virus-based therapeutics
Zhang, Q., Wu, W., Zhang, J., & Xia, X. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2021.1865304 · Cited by 8
Preclinical development of a vaccine-based immunotherapy regimen (VBIR) that induces potent and durable T cell responses to tumor-associated self-antigens
Cho, H., Binder, J., Weeratna, R. D., Dermyer, M. R., Dai, S., Boccia, A., Li, W., Li, S., Jooss, K. U., Merson, J. R., et al. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03245-x · Cited by 7
Nanotechnology-based delivery for CRISPR-Cas 9 cargo in Alzheimer's disease
Rawal, S. U., Khodakiya, A., & Prajapati, B. G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13205-6.00012-1 · Cited by 8
In-vivo transfection of the proopiomelanocortin gene, precursor of endogenous endorphin, by use of radial shock waves alleviates neuropathic pain
Ishikawa, T., Miyagi, M., Kamoda, H., Arai, G., Suzuki, M., Sakuma, Y., Oikawa, Y., Orita, S., Inoue, G., Takahashi, K., et al. (2013) · Journal of Orthopaedic Science · doi:10.1007/s00776-013-0397-y · Cited by 8
In silico structure analysis and epitope prediction of E3 CR1-beta protein of Human Adenovirus E for vaccine design
Patwary, N. I. A., Islam, M. S., Sohel, M., Ara, I., Sikder, M. O. F., & Shahik, S. M. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.11.004 · Cited by 8
Is it possible to ensure COVID19 vaccine supply by using plants?
Bhar, A. (2021) · The Nucleus · doi:10.1007/s13237-021-00361-4 · Cited by 8
Dengue Vaccination: Towards a New Dawn of Curbing Dengue Infection
Jain, S., Vimal, N., Angmo, N., Sengupta, M., & Thangaraj, S. (2023) · Immunological Investigations · doi:10.1080/08820139.2023.2280698 · Cited by 7
Vaccine Strategy That Enhances the Protective Efficacy of Systemic Immunization by Establishing Lung-Resident Memory CD8 T Cells Against Influenza Infection
Kong, H.-J., Choi, Y., Kim, E.-A., & Chang, J. (2023) · Immune Network · doi:10.4110/in.2023.23.e32 · Cited by 7
Seroprevalence of human adenovirus type 5 neutralizing antibodies in the Philippines
Francisco, A. G., Reyes, J. C. B., Tabios, I. K. B., Cruz, C. J. G., Ang, M. A. C., Heralde, F. M., Lacuna, A. R. G., & de Paz‐Silava, S. L. M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293046 · Cited by 7
From intramuscular to nasal: unleashing the potential of nasal spray vaccines against coronavirus disease 2019
Jin, G., Wang, R., Jin, Y., Song, Y., & Wang, T. (2024) · Clinical & Translational Immunology · doi:10.1002/cti2.1514 · Cited by 7
Priming with two DNA vaccines expressing hepatitis C virus NS3 protein targeting dendritic cells elicits superior heterologous protective potential in mice
Guan, J., Deng, Y. L., Chen, H., Yin, X., Yang, Y., & Tan, W. (2015) · Archives of Virology · doi:10.1007/s00705-015-2535-7 · Cited by 7
A Recombinant Adenovirus Expressing Ovine Interferon Tau Prevents Influenza Virus-Induced Lethality in Mice
Martı́n, V., Pascual, E., Avia, M., Rangel, G. A., de Molina-Iracheta, A., Alejo, A., & Sevilla, N. (2016) · Journal of Virology · doi:10.1128/jvi.03258-15 · Cited by 7
Proteomic Analysis of Adenovirus 5 by UHPLC-MS/MS: Development of a Robust and Reproducible Sample Preparation Workflow
Zarei, M., Jonveaux, J., Wang, P., Haller, F. M., Gu, B., Koulov, A. V., & Jahn, M. (2022) · ACS Omega · doi:10.1021/acsomega.2c05325 · Cited by 7
Virus-like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development
Castilho, L. R., de Mattos, N. R., Abreu, W. S., & Gutarra, M. L. E. (2022) · Biologics · doi:10.3390/biologics2040018 · Cited by 7
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Valenzuela-Fernández, A., Cabrera-Rodríguez, R., Ciuffreda, L., Pérez-Yanes, S., Estévez‐Herrera, J., González‐Montelongo, R., Alcoba-Flórez, J., Trujillo‐González, R., de Artola, D. G.-M., Gil-Campesino, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1052436 · Cited by 8
Evaluation of the genotype I Japanese encephalitis virus as a stable viral vector for foreign gene expression
Li, C., Zhang, L., Chen, X., Jiang, D., Hu, J., Guo, J., Ding, J., Xue, J., Bao, W., & Lǐ, Y. (2023) · Antiviral Research · doi:10.1016/j.antiviral.2023.105652 · Cited by 8
Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice
Maunder, H. E., Taylor, G., Leppard, K. N., & Easton, A. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.10.105 · Cited by 7
Flagellin FljB as an adjuvant to the recombinant adenovirus rabies glycoprotein vaccine increases immune responses against rabies in mice
Xiao, X., Zhang, Y., Wei, Q., & Yin, X. (2017) · Archives of Virology · doi:10.1007/s00705-017-3413-2 · Cited by 7
Replication deficient human adenovirus vector serotype 19a/64: Immunogenicity in mice and female cynomolgus macaques
Ragonnaud, E., Schroedel, S., Mariya, S., Iskandriati, D., Pamungkas, J., Fougeroux, C. E., Daradoumis, J., Thomsen, A. R., Neukirch, L., Ruzsics, Z., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.07.075 · Cited by 7
Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of Adenovirus Vector-Based COVID-19 Vaccines?
Lee, H., Punt, J. A., Patel, J., Stojanovic, M. P., Duszynski, B. S., & McCormick, Z. L. (2021) · Pain Medicine · doi:10.1093/pm/pnab130 · Cited by 6
ADENOVIRUS BASED VACCINES GENERATE CYTOTOXIC T LYMPHOCYTES TO EPITOPES OF NS1 FROM DENGUE VIRUS THAT ARE PRESENT IN ALL MAJOR SEROTYPES
Gao, G., Wang, Q., Dai, Z., Calcedo, R., Sun, X., Li, G., & Wilson, J. M. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.011 · Cited by 7
Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery
Steinstraesser, L., Sorkin, M., Jacobsen, F., Al‐Benna, S., Kesting, M. R., Niederbichler, A. D., Otte, J., Hirsch, T., Stupka, J., Steinau, H., et al. (2011) · BMC Immunology · doi:10.1186/1471-2172-12-8 · Cited by 7
Seroprevalence of Human Adenovirus Type 5 Neutralizing Antibody in Common Marmosets Determined by a New Set of Two Assays
Wang, Q. M., Sun, Y., Xu, Y., Wang, Y., Wang, H., Fu, Y., Allain, J., Li, C.-Y., & Li, T. (2019) · Viral Immunology · doi:10.1089/vim.2019.0054 · Cited by 7
Research advances in replication-deficient viral vector vaccines
Wang, J., Cui, J., Li, G., & Yu, L. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1535328 · Cited by 6
Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre–Fusion Spike Glycoproteins Protects Non–Human Primates against SARS-CoV-2 Infection
Wang, S., Qin, M., Xu, L., Mu, T., Zhao, P., Sun, B., Wu, Y., Song, L., Wu, H., Wang, W., et al. (2023) · Vaccines · doi:10.3390/vaccines11091427 · Cited by 6
Understanding COVID-19 Vaccines and Their Development
Patel, S. S., Kalma, J. J., & Bluman, E. M. (2020) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.01191 · Cited by 6
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process
Nie, J., Sun, Y., Feng, K., Huang, L., Li, Y., & Bai, Z. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.02.024 · Cited by 6
Immune Regulatory Effect of Osteopontin Gene Therapy in a Murine Model of Multidrug Resistant Pulmonary Tuberculosis
Hernández-Bazán, S., Mata‐Espinosa, D., Lozano-Ordaz, V., Ramos‐Espinosa, O., Barrios‐Payán, J., López‐Casillas, F., & Hernández‐Pando, R. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.030 · Cited by 6
Development and characterization of a vector system based on the simian adenovirus type 25
Ozharovskaia, T. A., Popova, O. D., Zubkova, O. V., Викторовна, В. И., Pochtovyy, A., Shcheblyakov, D. V., Gushchin, V. А., Logunov, D., & Al, G. (2023) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2023.006 · Cited by 6
Development of SARS-CoV-2 Vaccine: Challenges and Prospects
Mahboob, T., Ismail, A. A., Shah, M. R., Rahmatullah, M., Paul, A. K., Pereira, M. D. L., Wiart, C., Wilairatana, P., Rajagopal, M. S., Dolma, K. G., et al. (2023) · Diseases · doi:10.3390/diseases11020064 · Cited by 6
Review on COVID-19 Vaccines
Majid, L., Radhakrishnan, S., Vignesh, R., & Muthukumarasamy, R. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00990 · Cited by 6
Adenovirus F protein as a delivery vehicle for botulinum B
Clapp, B., Golden, S. M., Maddaloni, M., Staats, H. F., & Pascual, D. W. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-36 · Cited by 6
A CD8 T-Cell Epitope Variant Enhances Immune Targeting to a Recombinant Picornavirus Vaccine Antigen
Bell, M. P., Renner, D. N., Johnson, A. J., & Pavelko, K. D. (2014) · Viral Immunology · doi:10.1089/vim.2014.0045 · Cited by 6
Correction: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
Kim, S., Kim, J., Choi, Y., Nguyen, H. H., Song, M., & Chang, J. (2013) · PLoS ONE · doi:10.1371/annotation/c2c0b5cc-ce3e-4c1f-a821-caed5697d72d · Cited by 6
Immune Modulation with Oral DNA/RNA Nanoparticles
Kart, U., Raimbekova, A., Yegorov, S., & Hortelano, G. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050609 · Cited by 5
Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system
Nie, J., Sun, Y., Ren, H., Huang, L., Feng, K., Li, Y., & Bai, Z. (2022) · Biotechnology Letters · doi:10.1007/s10529-022-03302-6 · Cited by 5
Addressing Inequality in the COVID-19 Pandemic in Africa: A Snapshot from Clinical Symptoms to Vaccine Distribution
Pêgo, A. C., Lima, I. S., & Gozzelino, R. (2024) · COVID · doi:10.3390/covid4020014 · Cited by 6
Isolation of a recombinant simian adenovirus encoding the human adenovirus G52 hexon suggests a simian origin for human adenovirus G52
Pinski, A. N., Gan, T., Lin, S., Droit, L., Diamond, M., Barouch, D. H., & Wang, D. (2024) · Journal of Virology · doi:10.1128/jvi.00043-24 · Cited by 5
Construction and immunological evaluation of recombinant adenovirus vaccines of new novel NADC34-PRRSV strains in pigs
Xie, C.-Z., Zhang, P., Wang, Z., Tao, Y.-M., Cui, Z.-D., Nan, F., Zhang, F.-C., Ren, Y.-X., Zhang, H., & Lu, H. (2024) · Frontiers in Veterinary Science · doi:10.3389/fvets.2024.1503526 · Cited by 5
A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products
Haut, L. H., Gill, A. L., Kurupati, R. K., Bian, A., Li, Y., Giles‐Davis, W., Xiang, Z., Zhou, X., & Ertl, H. C. J. (2016) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.044 · Cited by 5
Self-citation
Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens
Young, K. G., Haq, K., MacLean, S., Dudani, R., Elahi, S. M., Gilbert, R., Weeratna, R. D., & Krishnan, L. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.12856 · Cited by 5
Generation of Replication Deficient Human Adenovirus 5 (Ad5) Vectored FMD Vaccines
Medina, G. N., Santos, T. D. L., & Segundo, F. D.-S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2168-4_9 · Cited by 5
Semi-quantification of antibody-dependent enhancement (ADE) in the uptake of Adenovirus serotype 5 into THP-1 cells
Valliyott, L., Dungdung, R., & Pilankatta, R. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.113568 · Cited by 5
Tuberculosis: laboratory diagnosis and treatment strategies
McHugh, T. D. (2013) · CABI eBooks · doi:10.1079/9781845938079.0000 · Cited by 5
Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes
Hosseini, S. Y., Sabahi, F., Moazzeni, S. M., Modarressi, M. H., Firoozi, M. S., & Ravanshad, M. (1970) · Hepatitis Monthly · doi:10.5812/hapatmon.6130 · Cited by 5
Side Effects and Immunogenicity Following Administration of The Sputnik V COVID-19 Vaccine Among Health Care Workers; An Observational Study in IranPreprint
Babamahmoodi, F., Saeedi, M., Alizadeh‐Navaei, R., Hedayatizadeh‐Omran, A., Mousavi, S. A., Ovaise, G., Kordi, S., Akbari, Z., Azordeh, M., Ahangarkani, F., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-709499/v1 · Cited by 5
Pooled Analysis of the Effect of Pre-Existing Ad5 Neutralizing Antibodies on the Immunogenicity of Adenovirus Type 5 Vector-Based COVID-19 Vaccine from Eight Clinical Trials
Liu, W., Li, Y., Li, X., Wang, F., Qi, R., Zhu, T., & Li, J. (2025) · Vaccines · doi:10.3390/vaccines13030333 · Cited by 4
Surface Modification of Adenovirus Vector to Improve Immunogenicity and Tropism
Gabal, Y., & Ramsey, J. D. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0795-4_18 · Cited by 4
Comparative analysis of existing platforms for the development of vaccines against dangerous and extremely dangerous viral infections with pandemic potential
Онищенко, Г. Г., Sizikova, T. E., Lebedev, V. N., & Borisevich, S. V. (2021) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2021-21-4-225-233 · Cited by 4
Immunogen characterization reveals an intrinsic hindrance in eliciting neutralizing antibodies against JN.1 variant
Fan, J., Zhang, Y., Li, S., Li, Q., Zi, Q., Mou, X., Zheng, J., Wang, X., Guo, X., Chen, J., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110405 · Cited by 4
Functional organization of the major late transcriptional unit of canine adenovirus type 2
Szelechowski, M., Fournier, A., Richardson, J. P., Éloit, M., & Klonjkowski, B. (2009) · Journal of General Virology · doi:10.1099/vir.0.007773-0 · Cited by 4
Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19?
Chang, K. P., Reynolds, J. M., Liu, Y., & He, J. J. (2022) · Vaccines · doi:10.3390/vaccines10020248 · Cited by 4
Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review
Lee, J. K., & Shin, O. S. (2022) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2021.01669 · Cited by 4
E4orf1 Suppresses E1B-Deleted Adenovirus Vaccine-Induced Immune Responses
Sangare, K., Hait, S. H., Moore, M., Hogge, C. J., Hoang, T. N., Rahman, M. A., Venzon, D. J., LaBranche, C. C., Montefiori, D. C., Robert-Guroff, M., et al. (2022) · Vaccines · doi:10.3390/vaccines10020295 · Cited by 4
Adeno-Associated Virus-Mediated Interleukin-12 Gene Expression Alleviates Lung Inflammation and Type 2 T-Helper-Responses in Ovalbumin-Sensitized Asthmatic Mice
Chiang, P., Chen, J., Chen, L., & Kuo, M. (2022) · Human Gene Therapy · doi:10.1089/hum.2022.034 · Cited by 4
Razrabotka i harakteristika vektornoj sistemy na osnove adenovirusa obez'yan 25-go serotipa
Ozharovskaia, T. A., Попова, О., Zubkova, O. V., Викторовна, В. И., Pochtovyy, A. A., Щебляков, Д. В., Алексеевич, Г. В., Логунов, Д. Ю., & Al, G. (2023) · Вестник Российского государственного медицинского университета · doi:10.24075/vrgmu.2023.006 · Cited by 4
Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia
Artarini, A., Hadianti, T., Giri-Rachman, E. A., Tan, M. I., Safitri, I. A., Hidayat, N. A., RETNONINGRUM, D. S., & Natalia, D. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00749-4 · Cited by 5
COVID-19 vaccines breakthrough infection and adverse reactions in medical students: a nationwide survey in Iran
Allahgholipour, A., Safavi‐Naini, S. A. A., Foomany, Z. S., Eskandari, A., Rostami, H. N., Honarvar, M., Mohammadi, M., Khalili, P., Ilaghi, M., Afshar, H., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1348015 · Cited by 4
Healthspan Extension through Innovative Genetic Medicines
Garcia, H., Brown, D. W., Scholz, M., & Lewis, J. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009674 · Cited by 6
Genetic medicine strategies to protect against bioterrorism.
Boyer, J. L., & Crystal, R. G. (2006) · PubMed · Cited by 4
[Molecular biology of adenoviral vectors].
Martínez‐Flores, F., Jiménez-Orozco, F. A., & Villegas-Castrejón, H. (2006) · PubMed · Cited by 4
Manipulation of the Bluetongue Virus Tubules for Immunogen Delivery
Murphy, A., & Roy, P. (2008) · Future Microbiology · doi:10.2217/17460913.3.3.351 · Cited by 4
Virus‐based immunotherapy of cancer: what do we know and where are we going?
Sørensen, M. R., & Thomsen, A. R. (2007) · Apmis · doi:10.1111/j.1600-0643.2007.00802.x · Cited by 4
Capsid-Incorporation Strategy To Display Antigens for an Alternative Adenoviral Vector Vaccine Approach
van Winkel, C. A. J., Moreno, A., & Curiel, D. T. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00591 · Cited by 4
Systemic and Mucosal Immune Responses Induced by Adenoviral-Vectored Consensus H5 Influenza A Vaccines in Mice and Swine
Madapong, A., Wiggins, J., DeBeauchamp, J., Webby, R. J., & Weaver, E. A. (2025) · Vaccines · doi:10.3390/vaccines13090928 · Cited by 4
A binary self-amplifying expression platform enabling lipid nanoparticle-free vaccines and nanomedicines
Jefferies, W. A., Choi, K. B., Ribeca, P., Kari, S., Young, J. B., Hui, E., Qi, S. Y., Garrovillas, E., Fan, J., Cho, B. M. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66252-3 · Cited by 5
Retinal gene therapies for inherited ocular diseases: Translational delivery strategies from bench to bedside
Haddadzadegan, S., Mehdizdeh, N., Wang, X., Wong, T. T. L., & Miserez, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114841 · Cited by 3
An Ad-Vectored H3N8 Avian influenza vaccine induces potent immunity and protection in mice and chickens
Nie, X., Lina, L. I. U., He, L., Xu, H., Wang, Y., Li, N., He, M., Ren, W., Sun, Y., Han, H., et al. (2026) · Veterinary Microbiology · doi:10.1016/j.vetmic.2026.111003 · Cited by 3
Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E
Zheng, Y.-P., Huang, L., Ding, H., Xu, H., Shu, R.-G., Yu, J., Peng, X.-L., Fu, Y.-H., & He, J. (2023) · Viruses · doi:10.3390/v15122288 · Cited by 3
Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner
Li, L., Zou, Y., Shen, C., Chen, N., Tong, M., Liu, R., Wang, J., & Ning, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36726 · Cited by 3
Efficient Amplification of Chimeric Adenovirus 5/40S Vectors Carrying the Short Fiber Protein of Ad40 in Suspension Cell Cultures
Miralles, M., Segura, M. M., Puig, M., Bosch, A., & Chillón, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042073 · Cited by 3
Analysis of adenovirus-induced immunity to infection with Listeria monocytogenes : Fading protection coincides with declining CD8 T cell numbers and phenotypic changes
Jahn, M. L., Steffensen, M. A., Christensen, J. P., & Thomsen, A. R. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.080 · Cited by 3
Gene Therapy: Use of Viruses as Vectors
Nance, M. E., & Duan, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95711-8 · Cited by 3
Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production
Mara, K., Dai, M., Brice, A. M., Alexander, M. R., Tribolet, L., Layton, D., & Bean, A. G. D. (2021) · Vaccines · doi:10.3390/vaccines9010059 · Cited by 3

Authors: Tatsis, N., & Ertl, H. C. J.
Affiliations: The Wistar Institute (US)
Corresponding author: Ertl, Hildegund C.J.
ORCID: Ertl, Hildegund C.J.
Venue: Molecular Therapy
Publisher: Elsevier BV
Published: 2004-10
Volume: 10
Issue: 4
Pages: 616-629
ISSN: 1525-0016 (ISSN-L)
DOI: 10.1016/j.ymthe.2004.07.013
PMC: PMC7106330
OpenAlex: W1972258033
Cited by: 669
References: 134
Citations by year: 2026: 16 · 2025: 28 · 2024: 31 · 2023: 60 · 2022: 58 · 2021: 69 · 2020: 26 · 2019: 25 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 24 · 2014: 21 · 2013: 28 · 2012: 23
FWCI: 3.15
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4389 d)
Locations: Molecular Therapy (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords: adenoviral vector, vaccine vectors, subunit vaccine, viral vaccines, innate immune response, adaptive immune response, transgene expression, HIV-1 vaccine, malaria vaccine, tumor-associated antigens
MeSH terms: Adenoviridae, Adenoviridae Infections, Genes, Viral, Genetic Vectors, Humans, Peptides, Viral Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adenoviruses as vaccine vectors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks